drugset / Trial / NCT02993718

Sedation by Dexmedetomidine and Propofol

NCT02993718 ↗

RandomizedParallel-groupSingle-blindSupportive care

Summary

Under the hypothesis that dexmedetomidine sedation would result in less upper airway obstruction, we evaluated the occurrence of upper airway collapse or the requirement of airway intervention in patients with obstructive sleep apnea during dexmedetomidine or propofol sedation.

Timeline

Start
2015-01
Primary completion
2017-06
Completion
2017-06

Outcome

Met primary endpoint

paper there was a significantly lower proportion of patients exhibiting signs of upper airway obstruction in the dexmedetomidine group than in the propofol group (11.5% vs. 41.7%, P = 0.035). PMID 30185146 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg —
Subject Dexmedetomidine Other / unclassified 0.8 ug/kg —
Subject Propofol Small molecule 0.5 ug/ml —
Subject Propofol Small molecule 2 ug/ml —

Indications

No indication recorded.